nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Prednisolone—psoriatic arthritis	0.0958	0.133	CbGbCtD
Cyclophosphamide—CYP2A6—Dexamethasone—psoriatic arthritis	0.0565	0.0785	CbGbCtD
Cyclophosphamide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0498	0.0692	CbGbCtD
Cyclophosphamide—CYP3A7—Dexamethasone—psoriatic arthritis	0.0386	0.0536	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0386	0.0536	CbGbCtD
Cyclophosphamide—CYP2C19—Prednisone—psoriatic arthritis	0.0374	0.052	CbGbCtD
Cyclophosphamide—CYP2B6—Dexamethasone—psoriatic arthritis	0.0368	0.0511	CbGbCtD
Cyclophosphamide—ABCB1—Betamethasone—psoriatic arthritis	0.0324	0.045	CbGbCtD
Cyclophosphamide—ABCB1—Prednisolone—psoriatic arthritis	0.032	0.0444	CbGbCtD
Cyclophosphamide—ABCB1—Prednisone—psoriatic arthritis	0.0302	0.0419	CbGbCtD
Cyclophosphamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0299	0.0415	CbGbCtD
Cyclophosphamide—CYP3A5—Dexamethasone—psoriatic arthritis	0.029	0.0402	CbGbCtD
Cyclophosphamide—CYP2C8—Dexamethasone—psoriatic arthritis	0.0279	0.0387	CbGbCtD
Cyclophosphamide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0234	0.0325	CbGbCtD
Cyclophosphamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0226	0.0314	CbGbCtD
Cyclophosphamide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0194	0.027	CbGbCtD
Cyclophosphamide—CYP3A4—Betamethasone—psoriatic arthritis	0.0194	0.027	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisolone—psoriatic arthritis	0.0192	0.0266	CbGbCtD
Cyclophosphamide—ABCB1—Dexamethasone—psoriatic arthritis	0.0189	0.0262	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisone—psoriatic arthritis	0.0181	0.0251	CbGbCtD
Cyclophosphamide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0178	0.0247	CbGbCtD
Cyclophosphamide—ABCB1—Methotrexate—psoriatic arthritis	0.0152	0.021	CbGbCtD
Cyclophosphamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0113	0.0157	CbGbCtD
Cyclophosphamide—Myocardial infarction—Prednisone—psoriatic arthritis	0.000251	0.000895	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00025	0.000892	CcSEcCtD
Cyclophosphamide—Malaise—Prednisolone—psoriatic arthritis	0.000248	0.000886	CcSEcCtD
Cyclophosphamide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000248	0.000885	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisolone—psoriatic arthritis	0.000238	0.000851	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisolone—psoriatic arthritis	0.000237	0.000848	CcSEcCtD
Cyclophosphamide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000235	0.000841	CcSEcCtD
Cyclophosphamide—Arrhythmia—Betamethasone—psoriatic arthritis	0.000235	0.000841	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000235	0.000838	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000234	0.000836	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisone—psoriatic arthritis	0.000234	0.000835	CcSEcCtD
Cyclophosphamide—Alopecia—Betamethasone—psoriatic arthritis	0.000233	0.000832	CcSEcCtD
Cyclophosphamide—Alopecia—Dexamethasone—psoriatic arthritis	0.000233	0.000832	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisolone—psoriatic arthritis	0.000231	0.000826	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisone—psoriatic arthritis	0.000231	0.000824	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00023	0.000821	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisone—psoriatic arthritis	0.00023	0.00082	CcSEcCtD
Cyclophosphamide—Erythema—Betamethasone—psoriatic arthritis	0.000229	0.00082	CcSEcCtD
Cyclophosphamide—Erythema—Dexamethasone—psoriatic arthritis	0.000229	0.00082	CcSEcCtD
Cyclophosphamide—Malaise—Triamcinolone—psoriatic arthritis	0.000228	0.000815	CcSEcCtD
Cyclophosphamide—Pancytopenia—Methotrexate—psoriatic arthritis	0.000228	0.000813	CcSEcCtD
Cyclophosphamide—Malaise—Methylprednisolone—psoriatic arthritis	0.000228	0.000813	CcSEcCtD
Cyclophosphamide—Oedema—Prednisolone—psoriatic arthritis	0.000224	0.000802	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000224	0.000802	CcSEcCtD
Cyclophosphamide—Shock—Prednisolone—psoriatic arthritis	0.000221	0.000789	CcSEcCtD
Cyclophosphamide—Cough—Triamcinolone—psoriatic arthritis	0.000221	0.000788	CcSEcCtD
Cyclophosphamide—Convulsion—Triamcinolone—psoriatic arthritis	0.000219	0.000783	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisolone—psoriatic arthritis	0.000219	0.000782	CcSEcCtD
Cyclophosphamide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000219	0.000781	CcSEcCtD
Cyclophosphamide—Hypertension—Triamcinolone—psoriatic arthritis	0.000218	0.00078	CcSEcCtD
Cyclophosphamide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000218	0.000778	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000217	0.000775	CcSEcCtD
Cyclophosphamide—Myalgia—Triamcinolone—psoriatic arthritis	0.000215	0.000769	CcSEcCtD
Cyclophosphamide—Pneumonia—Methotrexate—psoriatic arthritis	0.000215	0.000768	CcSEcCtD
Cyclophosphamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000215	0.000767	CcSEcCtD
Cyclophosphamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000215	0.000767	CcSEcCtD
Cyclophosphamide—Flushing—Prednisone—psoriatic arthritis	0.000213	0.000761	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000213	0.000761	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000213	0.000761	CcSEcCtD
Cyclophosphamide—Discomfort—Triamcinolone—psoriatic arthritis	0.000213	0.00076	CcSEcCtD
Cyclophosphamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000212	0.000758	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000212	0.000757	CcSEcCtD
Cyclophosphamide—Renal failure—Methotrexate—psoriatic arthritis	0.00021	0.00075	CcSEcCtD
Cyclophosphamide—Stomatitis—Methotrexate—psoriatic arthritis	0.000208	0.000744	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000208	0.000742	CcSEcCtD
Cyclophosphamide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000208	0.000742	CcSEcCtD
Cyclophosphamide—Malaise—Dexamethasone—psoriatic arthritis	0.000207	0.000739	CcSEcCtD
Cyclophosphamide—Malaise—Betamethasone—psoriatic arthritis	0.000207	0.000739	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000206	0.000737	CcSEcCtD
Cyclophosphamide—Oedema—Triamcinolone—psoriatic arthritis	0.000206	0.000737	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000206	0.000736	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisone—psoriatic arthritis	0.000205	0.000733	CcSEcCtD
Cyclophosphamide—Infection—Triamcinolone—psoriatic arthritis	0.000205	0.000732	CcSEcCtD
Cyclophosphamide—Sweating—Methotrexate—psoriatic arthritis	0.000205	0.000732	CcSEcCtD
Cyclophosphamide—Infection—Methylprednisolone—psoriatic arthritis	0.000205	0.000731	CcSEcCtD
Cyclophosphamide—Haematuria—Methotrexate—psoriatic arthritis	0.000204	0.000728	CcSEcCtD
Cyclophosphamide—Shock—Triamcinolone—psoriatic arthritis	0.000203	0.000725	CcSEcCtD
Cyclophosphamide—Alopecia—Prednisone—psoriatic arthritis	0.000203	0.000725	CcSEcCtD
Cyclophosphamide—Shock—Methylprednisolone—psoriatic arthritis	0.000203	0.000724	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000202	0.00072	CcSEcCtD
Cyclophosphamide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000201	0.00072	CcSEcCtD
Cyclophosphamide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000201	0.000718	CcSEcCtD
Cyclophosphamide—Erythema—Prednisone—psoriatic arthritis	0.0002	0.000714	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0002	0.000713	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000199	0.000712	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000199	0.000711	CcSEcCtD
Cyclophosphamide—Convulsion—Dexamethasone—psoriatic arthritis	0.000199	0.00071	CcSEcCtD
Cyclophosphamide—Convulsion—Betamethasone—psoriatic arthritis	0.000199	0.00071	CcSEcCtD
Cyclophosphamide—Hypertension—Dexamethasone—psoriatic arthritis	0.000198	0.000708	CcSEcCtD
Cyclophosphamide—Hypertension—Betamethasone—psoriatic arthritis	0.000198	0.000708	CcSEcCtD
Cyclophosphamide—Myalgia—Dexamethasone—psoriatic arthritis	0.000195	0.000698	CcSEcCtD
Cyclophosphamide—Myalgia—Betamethasone—psoriatic arthritis	0.000195	0.000698	CcSEcCtD
Cyclophosphamide—Discomfort—Dexamethasone—psoriatic arthritis	0.000193	0.000689	CcSEcCtD
Cyclophosphamide—Discomfort—Betamethasone—psoriatic arthritis	0.000193	0.000689	CcSEcCtD
Cyclophosphamide—Haemoglobin—Methotrexate—psoriatic arthritis	0.000193	0.000689	CcSEcCtD
Cyclophosphamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000192	0.000687	CcSEcCtD
Cyclophosphamide—Pain—Prednisolone—psoriatic arthritis	0.000192	0.000686	CcSEcCtD
Cyclophosphamide—Hepatitis—Methotrexate—psoriatic arthritis	0.000192	0.000685	CcSEcCtD
Cyclophosphamide—Haemorrhage—Methotrexate—psoriatic arthritis	0.000192	0.000685	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisone—psoriatic arthritis	0.000188	0.000673	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000188	0.000672	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000188	0.00067	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000187	0.000669	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000187	0.000669	CcSEcCtD
Cyclophosphamide—Oedema—Dexamethasone—psoriatic arthritis	0.000187	0.000669	CcSEcCtD
Cyclophosphamide—Oedema—Betamethasone—psoriatic arthritis	0.000187	0.000669	CcSEcCtD
Cyclophosphamide—Infection—Dexamethasone—psoriatic arthritis	0.000186	0.000665	CcSEcCtD
Cyclophosphamide—Infection—Betamethasone—psoriatic arthritis	0.000186	0.000665	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000185	0.000662	CcSEcCtD
Cyclophosphamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000185	0.000662	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000185	0.000661	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000185	0.000661	CcSEcCtD
Cyclophosphamide—Visual impairment—Methotrexate—psoriatic arthritis	0.000185	0.00066	CcSEcCtD
Cyclophosphamide—Anaemia—Prednisone—psoriatic arthritis	0.000185	0.00066	CcSEcCtD
Cyclophosphamide—Shock—Betamethasone—psoriatic arthritis	0.000184	0.000658	CcSEcCtD
Cyclophosphamide—Shock—Dexamethasone—psoriatic arthritis	0.000184	0.000658	CcSEcCtD
Cyclophosphamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000184	0.000657	CcSEcCtD
Cyclophosphamide—Agitation—Prednisone—psoriatic arthritis	0.000184	0.000656	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000183	0.000655	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000183	0.000655	CcSEcCtD
Cyclophosphamide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000183	0.000653	CcSEcCtD
Cyclophosphamide—Tachycardia—Betamethasone—psoriatic arthritis	0.000183	0.000653	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000181	0.000648	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000181	0.000647	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000181	0.000647	CcSEcCtD
Cyclophosphamide—Malaise—Prednisone—psoriatic arthritis	0.00018	0.000644	CcSEcCtD
Cyclophosphamide—Tinnitus—Methotrexate—psoriatic arthritis	0.000179	0.000639	CcSEcCtD
Cyclophosphamide—Anorexia—Betamethasone—psoriatic arthritis	0.000179	0.000638	CcSEcCtD
Cyclophosphamide—Anorexia—Dexamethasone—psoriatic arthritis	0.000179	0.000638	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisolone—psoriatic arthritis	0.000178	0.000637	CcSEcCtD
Cyclophosphamide—Fatigue—Triamcinolone—psoriatic arthritis	0.000178	0.000636	CcSEcCtD
Cyclophosphamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000178	0.000634	CcSEcCtD
Cyclophosphamide—Pain—Triamcinolone—psoriatic arthritis	0.000177	0.00063	CcSEcCtD
Cyclophosphamide—Hypotension—Dexamethasone—psoriatic arthritis	0.000175	0.000625	CcSEcCtD
Cyclophosphamide—Hypotension—Betamethasone—psoriatic arthritis	0.000175	0.000625	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisone—psoriatic arthritis	0.000173	0.000618	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisone—psoriatic arthritis	0.000173	0.000616	CcSEcCtD
Cyclophosphamide—Chills—Methotrexate—psoriatic arthritis	0.000172	0.000615	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000171	0.000609	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000171	0.000609	CcSEcCtD
Cyclophosphamide—Myalgia—Prednisone—psoriatic arthritis	0.00017	0.000608	CcSEcCtD
Cyclophosphamide—Arthralgia—Prednisone—psoriatic arthritis	0.00017	0.000608	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00017	0.000608	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00017	0.000606	CcSEcCtD
Cyclophosphamide—Alopecia—Methotrexate—psoriatic arthritis	0.00017	0.000606	CcSEcCtD
Cyclophosphamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000168	0.000601	CcSEcCtD
Cyclophosphamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000168	0.000601	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisone—psoriatic arthritis	0.000168	0.0006	CcSEcCtD
Cyclophosphamide—Erythema—Methotrexate—psoriatic arthritis	0.000167	0.000597	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000165	0.000591	CcSEcCtD
Cyclophosphamide—Urticaria—Triamcinolone—psoriatic arthritis	0.000164	0.000586	CcSEcCtD
Cyclophosphamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000164	0.000584	CcSEcCtD
Cyclophosphamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000164	0.000584	CcSEcCtD
Cyclophosphamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000163	0.000583	CcSEcCtD
Cyclophosphamide—Oedema—Prednisone—psoriatic arthritis	0.000163	0.000583	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000163	0.000583	CcSEcCtD
Cyclophosphamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000163	0.000582	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000163	0.000582	CcSEcCtD
Cyclophosphamide—Infection—Prednisone—psoriatic arthritis	0.000162	0.000579	CcSEcCtD
Cyclophosphamide—Fatigue—Dexamethasone—psoriatic arthritis	0.000161	0.000577	CcSEcCtD
Cyclophosphamide—Fatigue—Betamethasone—psoriatic arthritis	0.000161	0.000577	CcSEcCtD
Cyclophosphamide—Shock—Prednisone—psoriatic arthritis	0.00016	0.000573	CcSEcCtD
Cyclophosphamide—Pain—Betamethasone—psoriatic arthritis	0.00016	0.000572	CcSEcCtD
Cyclophosphamide—Pain—Dexamethasone—psoriatic arthritis	0.00016	0.000572	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisone—psoriatic arthritis	0.000159	0.000569	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000158	0.000563	CcSEcCtD
Cyclophosphamide—Vision blurred—Methotrexate—psoriatic arthritis	0.000157	0.000562	CcSEcCtD
Cyclophosphamide—Anorexia—Prednisone—psoriatic arthritis	0.000155	0.000555	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000155	0.000554	CcSEcCtD
Cyclophosphamide—Anaemia—Methotrexate—psoriatic arthritis	0.000154	0.000551	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000154	0.000551	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000154	0.000551	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000152	0.000543	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000152	0.000542	CcSEcCtD
Cyclophosphamide—Malaise—Methotrexate—psoriatic arthritis	0.000151	0.000538	CcSEcCtD
Cyclophosphamide—Leukopenia—Methotrexate—psoriatic arthritis	0.00015	0.000534	CcSEcCtD
Cyclophosphamide—Urticaria—Betamethasone—psoriatic arthritis	0.000149	0.000531	CcSEcCtD
Cyclophosphamide—Urticaria—Dexamethasone—psoriatic arthritis	0.000149	0.000531	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000149	0.000531	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisolone—psoriatic arthritis	0.000148	0.00053	CcSEcCtD
Cyclophosphamide—Asthenia—Triamcinolone—psoriatic arthritis	0.000148	0.000529	CcSEcCtD
Cyclophosphamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000148	0.000529	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000148	0.000529	CcSEcCtD
Cyclophosphamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000148	0.000528	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisone—psoriatic arthritis	0.000146	0.000523	CcSEcCtD
Cyclophosphamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000146	0.000522	CcSEcCtD
Cyclophosphamide—Cough—Methotrexate—psoriatic arthritis	0.000146	0.000521	CcSEcCtD
Cyclophosphamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000146	0.00052	CcSEcCtD
Cyclophosphamide—Convulsion—Methotrexate—psoriatic arthritis	0.000145	0.000517	CcSEcCtD
Cyclophosphamide—Myalgia—Methotrexate—psoriatic arthritis	0.000142	0.000508	CcSEcCtD
Cyclophosphamide—Chest pain—Methotrexate—psoriatic arthritis	0.000142	0.000508	CcSEcCtD
Cyclophosphamide—Arthralgia—Methotrexate—psoriatic arthritis	0.000142	0.000508	CcSEcCtD
Cyclophosphamide—Decreased appetite—Prednisone—psoriatic arthritis	0.000142	0.000506	CcSEcCtD
Cyclophosphamide—Rash—Prednisolone—psoriatic arthritis	0.000142	0.000505	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisolone—psoriatic arthritis	0.000141	0.000505	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000141	0.000503	CcSEcCtD
Cyclophosphamide—Fatigue—Prednisone—psoriatic arthritis	0.000141	0.000502	CcSEcCtD
Cyclophosphamide—Headache—Prednisolone—psoriatic arthritis	0.000141	0.000502	CcSEcCtD
Cyclophosphamide—Discomfort—Methotrexate—psoriatic arthritis	0.00014	0.000502	CcSEcCtD
Cyclophosphamide—Constipation—Prednisone—psoriatic arthritis	0.000139	0.000498	CcSEcCtD
Cyclophosphamide—Confusional state—Methotrexate—psoriatic arthritis	0.000137	0.000491	CcSEcCtD
Cyclophosphamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000136	0.000488	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000136	0.000487	CcSEcCtD
Cyclophosphamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000136	0.000486	CcSEcCtD
Cyclophosphamide—Infection—Methotrexate—psoriatic arthritis	0.000135	0.000484	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000134	0.00048	CcSEcCtD
Cyclophosphamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000134	0.00048	CcSEcCtD
Cyclophosphamide—Asthenia—Betamethasone—psoriatic arthritis	0.000134	0.00048	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000133	0.000477	CcSEcCtD
Cyclophosphamide—Nausea—Prednisolone—psoriatic arthritis	0.000133	0.000476	CcSEcCtD
Cyclophosphamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000133	0.000473	CcSEcCtD
Cyclophosphamide—Pruritus—Betamethasone—psoriatic arthritis	0.000133	0.000473	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000132	0.000471	CcSEcCtD
Cyclophosphamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000131	0.000469	CcSEcCtD
Cyclophosphamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000131	0.000468	CcSEcCtD
Cyclophosphamide—Rash—Triamcinolone—psoriatic arthritis	0.00013	0.000465	CcSEcCtD
Cyclophosphamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00013	0.000464	CcSEcCtD
Cyclophosphamide—Anorexia—Methotrexate—psoriatic arthritis	0.00013	0.000464	CcSEcCtD
Cyclophosphamide—Rash—Methylprednisolone—psoriatic arthritis	0.00013	0.000464	CcSEcCtD
Cyclophosphamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00013	0.000463	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisone—psoriatic arthritis	0.00013	0.000463	CcSEcCtD
Cyclophosphamide—Headache—Triamcinolone—psoriatic arthritis	0.000129	0.000462	CcSEcCtD
Cyclophosphamide—Headache—Methylprednisolone—psoriatic arthritis	0.000129	0.000461	CcSEcCtD
Cyclophosphamide—Body temperature increased—Prednisone—psoriatic arthritis	0.000129	0.000461	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000128	0.000458	CcSEcCtD
Cyclophosphamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000128	0.000458	CcSEcCtD
Cyclophosphamide—Hypotension—Methotrexate—psoriatic arthritis	0.000127	0.000455	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000124	0.000444	CcSEcCtD
Cyclophosphamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000124	0.000442	CcSEcCtD
Cyclophosphamide—Dizziness—Betamethasone—psoriatic arthritis	0.000124	0.000442	CcSEcCtD
Cyclophosphamide—Nausea—Triamcinolone—psoriatic arthritis	0.000123	0.000438	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000122	0.000437	CcSEcCtD
Cyclophosphamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000122	0.000437	CcSEcCtD
Cyclophosphamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000122	0.000434	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00012	0.000429	CcSEcCtD
Cyclophosphamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000119	0.000425	CcSEcCtD
Cyclophosphamide—Vomiting—Betamethasone—psoriatic arthritis	0.000119	0.000425	CcSEcCtD
Cyclophosphamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000118	0.000423	CcSEcCtD
Cyclophosphamide—Rash—Dexamethasone—psoriatic arthritis	0.000118	0.000422	CcSEcCtD
Cyclophosphamide—Rash—Betamethasone—psoriatic arthritis	0.000118	0.000422	CcSEcCtD
Cyclophosphamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000118	0.000421	CcSEcCtD
Cyclophosphamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000118	0.000421	CcSEcCtD
Cyclophosphamide—Fatigue—Methotrexate—psoriatic arthritis	0.000118	0.00042	CcSEcCtD
Cyclophosphamide—Headache—Dexamethasone—psoriatic arthritis	0.000117	0.000419	CcSEcCtD
Cyclophosphamide—Headache—Betamethasone—psoriatic arthritis	0.000117	0.000419	CcSEcCtD
Cyclophosphamide—Asthenia—Prednisone—psoriatic arthritis	0.000117	0.000418	CcSEcCtD
Cyclophosphamide—Pain—Methotrexate—psoriatic arthritis	0.000117	0.000416	CcSEcCtD
Cyclophosphamide—Pruritus—Prednisone—psoriatic arthritis	0.000115	0.000412	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000112	0.000401	CcSEcCtD
Cyclophosphamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000112	0.000399	CcSEcCtD
Cyclophosphamide—Nausea—Betamethasone—psoriatic arthritis	0.000111	0.000397	CcSEcCtD
Cyclophosphamide—Nausea—Dexamethasone—psoriatic arthritis	0.000111	0.000397	CcSEcCtD
Cyclophosphamide—Urticaria—Methotrexate—psoriatic arthritis	0.000108	0.000387	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisone—psoriatic arthritis	0.000108	0.000385	CcSEcCtD
Cyclophosphamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000108	0.000385	CcSEcCtD
Cyclophosphamide—Vomiting—Prednisone—psoriatic arthritis	0.000104	0.00037	CcSEcCtD
Cyclophosphamide—Rash—Prednisone—psoriatic arthritis	0.000103	0.000367	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisone—psoriatic arthritis	0.000103	0.000367	CcSEcCtD
Cyclophosphamide—Headache—Prednisone—psoriatic arthritis	0.000102	0.000365	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.0001	0.000359	CcSEcCtD
Cyclophosphamide—Asthenia—Methotrexate—psoriatic arthritis	9.78e-05	0.000349	CcSEcCtD
Cyclophosphamide—Nausea—Prednisone—psoriatic arthritis	9.69e-05	0.000346	CcSEcCtD
Cyclophosphamide—Pruritus—Methotrexate—psoriatic arthritis	9.64e-05	0.000344	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methotrexate—psoriatic arthritis	9.33e-05	0.000333	CcSEcCtD
Cyclophosphamide—Dizziness—Methotrexate—psoriatic arthritis	9.01e-05	0.000322	CcSEcCtD
Cyclophosphamide—Vomiting—Methotrexate—psoriatic arthritis	8.67e-05	0.00031	CcSEcCtD
Cyclophosphamide—Rash—Methotrexate—psoriatic arthritis	8.59e-05	0.000307	CcSEcCtD
Cyclophosphamide—Dermatitis—Methotrexate—psoriatic arthritis	8.59e-05	0.000307	CcSEcCtD
Cyclophosphamide—Headache—Methotrexate—psoriatic arthritis	8.54e-05	0.000305	CcSEcCtD
Cyclophosphamide—Nausea—Methotrexate—psoriatic arthritis	8.1e-05	0.000289	CcSEcCtD
